Daily Roundup

EYE.ASX RHT.ASX BMT.ASX FLT.ASX IFT.ASX

EYE Lifts Sales Guidance

Nova Eye Medical Ltd announces a new monthly sales record in the USA in April 2026, with group trailing twelve-month sales up 26% to US$22.8 million. The company has upgraded its FY26 sales guidance (excluding China) to US$22-23 million.

Resonance Health Upgrades FY26 Profit Guidance

Resonance Health has upgraded its FY26 underlying EBITDA guidance to approximately $2.6 million, a 30% increase, driven by improved operational performance, margin expansion, and disciplined cost control. While FY26 revenue is now expected to be slightly below previous guidance, this primarily reflects timing of revenue recognition.

Beamtree Wins $2m Saudi Contract, Provides Strategic Review Update

Beamtree Holdings Ltd has secured a $2 million contract with Fakeeh Group in Saudi Arabia and provided an interim update on its ongoing strategic review. The company is taking decisive action to reset its cost base and concentrate investment behind its highest-growth product lines.

Flight Centre Reports Trading and Guidance Updates

Flight Centre Travel Group has reported strong financial results for the first 9 months of FY26, with UPBT up 9.7% and TTV up 7.6%. The corporate and leisure divisions both delivered solid growth, though the leisure business was more impacted by recent geopolitical tensions. The company is launching a new loyalty program and continuing to invest in AI and technology.

CDC Signs 555MW Data Centre Contract with US Customer

CDC Data Centres has secured the largest data centre contract in Australia's history, a 555MW deal with a US high-end investment grade customer. The capacity will be delivered across CDC campuses over FY28 and FY29, taking CDC's total contracted capacity to over 1GW.